$NORD

AdvanSource Biomaterials Corp

CIK:0001011060|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue
Operating expenses:
Officer compensation	115,354	65,354
Professional fees	222,587	277,771
General and administrative	43,798	65,112
Research and development	437,885	423,649
Total operating expenses	819,624	831,886
Loss from operations	(819,624)	(831,886)
Other (expense) income:
Interest expense - related party	(1,942)
Change in fair value of investment	(1,487,000)	(375,000)
Total other expense	(1,488,942)	(375,000)
Loss before provision for income taxes	(2,308,566)	(1,206,886)
Provision for income tax
Net loss	(2,308,566)	(1,206,886)
Net loss attributable to non-controlling interests	(32,264)
Net loss attributable to Nordicus Partners Corporation	(2,276,302)	(1,206,886)
Other comprehensive income (loss):
Foreign currency translation adjustment	(540,292)	5,192,630
Comprehensive income (loss)	(2,848,858)	3,985,744
Net comprehensive income attributable to non-controlling interests	699
Comprehensive income (loss) attributable to Nordicus Partners Corporation	$ (2,817,293)	$ 3,985,744
Net loss per share attributable to Nordicus Partners Corporation - basic	$ (0.13)	$ (0.07)
Net loss per share attributable to Nordicus Partners Corporation - diluted	$ (0.13)	$ (0.07)
Weighted average common shares outstanding - basic	19,167,467	17,291,062
Weighted average common shares outstanding - diluted	19,167,467	17,291,062

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (2,308,566)	$ (1,206,886)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of investment	1,487,000	375,000
Amortization of website costs	1,298
Changes in assets and liabilities:
Prepaid expenses and other current assets	(116,727)	(114,969)
Other assets	11,053	23,325
Accounts payable and accrued expenses	752,982	609,328
Deferred revenue		(2,500)
Foreign currency remeasurement	13,116	(108,996)
Net cash used in operating activities	(159,844)	(425,698)
Cash flows from investing activities:
Proceeds from sale of plant, property, and equipment	7,618
Purchase of plant, property, and equipment	(8,794)
Net cash used in investing activities	(1,176)
Cash flows from financing activities:
Proceeds from issuance of common stock	123,750	409,970
Proceeds from issuance of notes payable - related party	22,000
Net cash provided by financing activities	145,750	409,970
Net change in cash	(15,270)	(15,728)
Effect of exchange rate on cash	176	4,232
Cash at beginning of period	20,878	19,914
Cash at end of period	5,784	8,418
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Mar. 31, 2026
Current assets:
Cash	$ 5,784	$ 20,878
Prepaid expenses and other current assets	292,618	512,006
Total current assets	298,402	532,884
In-process research and development	45,092,131	45,506,471
Property, plant, and equipment, net	8,369	8,207
Goodwill	26,913,697	27,161,000
Investment in Mag Mile Capital, Inc.	763,000	2,250,000
Other assets	24,220	4,784
Total assets	73,099,819	75,463,346
Current liabilities:
Accounts payable and accrued expenses	1,584,775	1,111,096
Notes payable - related party	82,000	60,000
Total current liabilities	1,666,775	1,171,096
Deferred tax liability	9,920,269	10,054,367
Total liabilities	11,587,044	11,225,463
Stockholders’ equity:
Common Stock; $0.001 par value; 50,000,000 shares authorized; 19,231,692 and 19,186,692 shares issued at June 30, 2026 and March 31, 2026, respectively; 19,173,896 and 19,128,896 shares outstanding at June 30, 2026 and March 31, 2026, respectively	19,232	19,187
Treasury stock; 57,796 and 57,796 shares at cost at June 30, 2026 and March 31, 2026, respectively	(108,722)	(108,722)
Additional paid-in capital	111,149,438	110,842,830
Accumulated other comprehensive income	3,773,908	4,314,899
Accumulated deficit	(53,245,739)	(50,786,534)
Total equity attributed to Nordicus Partners Corporation	61,588,117	64,281,660
Non-controlling interest	(75,342)	(43,777)
Total stockholders’ equity	61,512,775	64,237,883
Total liabilities and stockholders’ equity	$ 73,099,819	$ 75,463,346